HSCS HeartSciences Inc.
Finance Services · Nasdaq · SEC CIK 1468492 · Fiscal year ends 04/30
Financial factors as of 2026-07-31 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-17.0%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin60.9%
Operating margin-209,733.1%
Net margin-227,024.2%
FCF margin—
EBITDA margin-209,135.3%
Returns
ROE-1,851.9%
ROA-201.7%
ROIC (approx.)—
Asset turnover0.00x
Leverage & solvency
Liabilities / assets154.4%
Debt / equity—
Current ratio0.14x
Interest coverage-11.78x
Cash quality & payout
Operating cash flow / net income0.66x
Accruals ratio-68.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-04-30 | FY20252025-04-30 | FY20242024-04-30 | FY20232023-04-30 | FY20222022-04-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $4,319 | $4,350 | $18,600 | $5,150 | $14,373 |
| Cost of revenue | $1,768 | $1,880 | $6,081 | $2,796 | $7,890 |
| Gross profit | $2,551 | $2,470 | $12,519 | $2,354 | $6,483 |
| R&D expense | $2.84M | $4.39M | $2.88M | $2.46M | $3.00M |
| SG&A expense | $5.58M | $3.97M | $3.44M | $3.65M | $1.71M |
| Operating income | -$8.41M | -$8.35M | -$6.31M | -$6.11M | -$4.71M |
| Interest expense | $753,041 | $500,453 | $354,080 | $243,174 | $371,619 |
| Income tax | $0 | $0 | — | — | — |
| Net income | -$9.14M | -$8.77M | -$6.61M | -$6.35M | -$4.83M |
| EBITDA | -$8.39M | -$8.31M | -$6.28M | -$6.09M | -$4.68M |
| EPS (basic) | -3.48 | -9.34 | -18.74 | -80.00 | -1.45 |
| EPS (diluted) | — | -9.34 | -18.74 | -80.00 | -1.45 |
| Dividends declared per share | 0.00 | 0.00 | — | — | — |
| Weighted avg. shares (diluted) | — | 938,257 | 352,520 | 79,506 | 3.32M |
| Balance sheet | |||||
| Cash & equivalents | $1.66M | $1.10M | $5.81M | $1.66M | $918,260 |
| Receivables | — | $4,350 | — | — | $2,321 |
| Inventory | $655,629 | $650,267 | $629,179 | $676,359 | $674,139 |
| Current assets | $2.58M | $2.17M | $7.35M | $2.70M | $1.93M |
| PP&E, net | $39,312 | $63,549 | $97,991 | $61,428 | $70,035 |
| Intangibles | $1.66M | $1.62M | $1.59M | — | — |
| Total assets | $5.26M | $4.22M | $9.50M | $3.29M | $2.09M |
| Current liabilities | $4.86M | $3.70M | $1.75M | $1.83M | $3.47M |
| Total liabilities | $5.04M | $4.02M | $2.19M | $3.06M | $8.15M |
| Shareholders' equity | $226,060 | $205,171 | $7.32M | $230,557 | -$6.06M |
| Shares outstanding | 3.19M | 1.12M | 676,598 | 101,332 | 3.32M |
| Cash flow statement | |||||
| Operating cash flow | -$7.43M | -$7.41M | -$6.07M | -$5.77M | -$3.64M |
| Capital expenditure | $3,554 | $3,157 | $64,455 | $18,308 | $1,932 |
| Free cash flow | -$7.43M | -$7.42M | -$6.13M | -$5.79M | -$3.65M |
| Investing cash flow | -$44,452 | -$30,188 | -$125,271 | -$18,308 | -$1,932 |
| Financing cash flow | $8.03M | $2.73M | $10.34M | $6.53M | $3.84M |
| Depreciation & amortization | $27,791 | $37,599 | $27,892 | $26,915 | $26,566 |
| Stock-based compensation | $1.31M | $249,884 | $405,025 | $248,307 | $68,396 |
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.